BIODESIX INC financial data

Symbol
BDSX on Nasdaq
Location
Louisville, CO
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 200% % -10%
Debt-to-equity 4271% % 949%
Return On Equity -1761% % -715%
Return On Assets -40% % 5.5%
Operating Margin -32% % 35%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9,858,358 shares -93%
Common Stock, Shares, Outstanding 8,253,053 shares 13%
Entity Public Float $19,600,000 USD -74%
Common Stock, Value, Issued $8,000 USD 14%
Weighted Average Number of Shares Outstanding, Basic 7,551,000 shares 17%
Weighted Average Number of Shares Outstanding, Diluted 7,551,000 shares 17%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $88,499,000 USD 24%
Research and Development Expense $12,001,000 USD 26%
Selling and Marketing Expense $7,562,000 USD -0.16%
Operating Income (Loss) $27,873,000 USD 19%
Nonoperating Income (Expense) $7,392,000 USD 12%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $35,265,000 USD 18%
Earnings Per Share, Basic -4.67 USD/shares 30%
Earnings Per Share, Diluted -4.67 USD/shares 30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $18,987,000 USD -28%
Accounts Receivable, after Allowance for Credit Loss, Current $9,036,000 USD 5%
Other Assets, Current $4,495,000 USD -3%
Assets, Current $32,518,000 USD -18%
Property, Plant and Equipment, Net $24,817,000 USD -11%
Operating Lease, Right-of-Use Asset $2,997,000 USD 70%
Intangible Assets, Net (Excluding Goodwill) $3,883,000 USD -34%
Goodwill $15,031,000 USD 0%
Other Assets, Noncurrent $8,230,000 USD 13%
Assets $87,476,000 USD -10%
Accounts Payable, Current $3,080,000 USD 40%
Employee-related Liabilities, Current $7,834,000 USD 16%
Accrued Liabilities, Current $11,033,000 USD 9.6%
Contract with Customer, Liability, Current $961,000 USD 42%
Liabilities, Current $17,436,000 USD 22%
Operating Lease, Liability, Noncurrent $24,039,000 USD -3.2%
Other Liabilities, Noncurrent $1,021,000 USD 25%
Liabilities $89,941,000 USD 18%
Retained Earnings (Accumulated Deficit) $497,762,000 USD -7.6%
Stockholders' Equity Attributable to Parent $2,465,000 USD -112%
Liabilities and Equity $87,476,000 USD -10%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $8,602,000 USD 44%
Net Cash Provided by (Used in) Financing Activities $97,000 USD -88%
Net Cash Provided by (Used in) Investing Activities $137,000 USD 50%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 8,253,053 shares 13%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,642,000 USD 42%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19,075,000 USD -28%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,379,000 USD -6.5%
Deferred Tax Assets, Valuation Allowance $106,525,000 USD 7.6%
Deferred Tax Assets, Gross $108,724,000 USD 7.7%
Operating Lease, Liability $25,403,000 USD -0.56%
Depreciation $900,000 USD -10%
Payments to Acquire Property, Plant, and Equipment $74,000 USD -68%
Lessee, Operating Lease, Liability, to be Paid $41,323,000 USD -6.3%
Property, Plant and Equipment, Gross $37,333,000 USD 1%
Operating Lease, Liability, Current $1,364,000 USD 90%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,302,000 USD 3.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $4,165,000 USD 16%
Operating Lease, Weighted Average Discount Rate, Percent 0.115 pure 0.88%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $15,920,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,390,000 USD 8%
Deferred Tax Assets, Operating Loss Carryforwards $85,688,000 USD 9.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $143,000 USD 198%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,482,000 USD 8%
Additional Paid in Capital $495,289,000 USD 2.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $2,028,000 USD 1%
Deferred Tax Assets, Net of Valuation Allowance $2,199,000 USD 14%
Share-based Payment Arrangement, Expense $4,139,000 USD -38%
Interest Expense $7,716,000 USD -6.6%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%